Salix Pharmaceuticals (SLXP) News Today → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free SLXP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineU.S. District Court Upholds Final Judgment for XIFAXAN(R) 550 mg That Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029benzinga.com - May 17 at 2:07 PMPharmaceuticals Newsbizjournals.com - April 6 at 1:49 AMWhy Salix Pharmaceuticals (SLXP) Stock Is Gaining Todaythestreet.com - February 19 at 6:37 AMSalix Pharmaceuticals (SLXP) Stock Closed Lower Today as Valeant Looks to Increase Bidthestreet.com - January 7 at 3:51 PMWhy Salix Pharmaceuticals (SLXP) Stock Is Soaring Todaythestreet.com - December 31 at 9:56 PMWhy Salix Pharmaceuticals (SLXP) Stock Is Surging Todaythestreet.com - December 25 at 3:26 PMValeant Pharmaceuticals (VRX) Stock Surges Today as Analyst Ups Price Target on Salix Dealthestreet.com - December 23 at 12:44 PMBausch Health Says FDA Won't Fully Approve Generic Xifaxan Until 2029marketwatch.com - September 9 at 9:59 AMSalix Acquisition Likely, but at What Price Is Open to Debatethestreet.com - September 4 at 6:34 PMBausch Health plummets 50% following judge's Xifaxan patent orderseekingalpha.com - July 28 at 4:28 PMDNDNQ Newsthestreet.com - July 18 at 9:25 PMSalix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2022markets.businessinsider.com - June 20 at 7:18 AMJim Cramer's 'Mad Money' Recap: Calm Down, There's No Nasdaq Bubblethestreet.com - June 1 at 8:29 AMStock Market Today: Futures Jump as Jobs Rebound in Septemberthestreet.com - January 6 at 8:19 AMCanada's Valeant to buy Salix in $10.1 billion dealfinance.yahoo.com - August 2 at 9:58 PM Get Salix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SLXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. SLXP Media Mentions By Week SLXP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLXP News Sentiment▼0.000.41▲Average News Sentiment SLXP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLXP Articles This Week▼00▲SLXP Articles Average Week Get Salix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SLXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLXP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salix Pharmaceuticals Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
